Quest Partners LLC Immunome Inc. Transaction History
Quest Partners LLC
- $920 Billion
- Q1 2025
A detailed history of Quest Partners LLC transactions in Immunome Inc. stock. As of the latest transaction made, Quest Partners LLC holds 53,788 shares of IMNM stock, worth $455,046. This represents 0.04% of its overall portfolio holdings.
Number of Shares
53,788
Previous 7,868
583.63%
Holding current value
$455,046
Previous $83.6 Million
333.22%
% of portfolio
0.04%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding IMNM
# of Institutions
149Shares Held
66.4MCall Options Held
47.3KPut Options Held
4.31M-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.55MShares$63.9 Million0.03% of portfolio
-
Redmile Group, LLC San Francisco, CA5.36MShares$45.4 Million3.79% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.36MShares$36.9 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.31MShares$36.4 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.08MShares$34.5 Million2.16% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $103M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...